These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1651903)

  • 21. Promotion of vesicular stomatitis virus fusion by the endosome-specific phospholipid bis(monoacylglycero)phosphate (BMP).
    Roth SL; Whittaker GR
    FEBS Lett; 2011 Mar; 585(6):865-9. PubMed ID: 21333650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosylation is not required for the fusion activity of the G protein of vesicular stomatitis virus in insect cells.
    Bailey MJ; McLeod DA; Kang CY; Bishop DH
    Virology; 1989 Apr; 169(2):323-31. PubMed ID: 2650461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilization and reconstitution of vesicular stomatitis virus envelope using octylglucoside.
    Paternostre M; Viard M; Meyer O; Ghanam M; Ollivon M; Blumenthal R
    Biophys J; 1997 Apr; 72(4):1683-94. PubMed ID: 9083672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino-terminal mutation of the vesicular stomatitis virus glycoprotein does not affect its fusion activity.
    Woodgett C; Rose JK
    J Virol; 1986 Aug; 59(2):486-9. PubMed ID: 3016308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
    Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
    J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-dependent fusion induced by vesicular stomatitis virus glycoprotein reconstituted into phospholipid vesicles.
    Eidelman O; Schlegel R; Tralka TS; Blumenthal R
    J Biol Chem; 1984 Apr; 259(7):4622-8. PubMed ID: 6323480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of epitopes associated with different biological activities on the glycoprotein of vesicular stomatitis virus by use of monoclonal antibodies.
    Nagata S; Okamoto Y; Inoue T; Ueno Y; Kurata T; Chiba J
    Arch Virol; 1992; 127(1-4):153-68. PubMed ID: 1280941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.
    Kahn JS; Schnell MJ; Buonocore L; Rose JK
    Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusogenic virosomes prepared by partitioning of vesicular stomatitis virus G protein into preformed vesicles.
    Hug P; Sleight RG
    J Biol Chem; 1994 Feb; 269(6):4050-6. PubMed ID: 8307962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G.
    Zhang L; Ghosh HP
    J Virol; 1994 Apr; 68(4):2186-93. PubMed ID: 8139003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probing the interaction between vesicular stomatitis virus and phosphatidylserine.
    Carneiro FA; Lapido-Loureiro PA; Cordo SM; Stauffer F; Weissmüller G; Bianconi ML; Juliano MA; Juliano L; Bisch PM; Da Poian AT
    Eur Biophys J; 2006 Jan; 35(2):145-54. PubMed ID: 16184389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New chemical method of viral inactivation for vaccine development based on membrane fusion inhibition.
    Stauffer F; De Miranda J; Schechter MC; Queiroz FA; Santos NO; Alves AM; Da Poian AT
    Vaccine; 2007 Nov; 25(46):7885-92. PubMed ID: 17949864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line.
    Roberts PC; Kipperman T; Compans RW
    J Virol; 1999 Dec; 73(12):10447-57. PubMed ID: 10559363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation inactivation analysis of fusion and hemolysis by vesicular stomatitis virus.
    Bundo-Morita K; Gibson S; Lenard J
    Virology; 1988 Apr; 163(2):622-4. PubMed ID: 2833025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
    Bachmann MF; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of certain inhibitors of glycoprotein synthesis on cell fusion induced by vesicular stomatitis virus.
    Takehara M
    Microbiol Immunol; 1979; 23(3):167-76. PubMed ID: 225643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charged residues are involved in membrane fusion mediated by a hydrophilic peptide located in vesicular stomatitis virus G protein.
    Carneiro FA; Vandenbussche G; Juliano MA; Juliano L; Ruysschaert JM; Da Poian AT
    Mol Membr Biol; 2006; 23(5):396-406. PubMed ID: 17060157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.